Noradrenergic Add-on Therapy With Guanfacine

Clinical trial NCT03116126 · UNKNOWN

Trial details

NCT number: NCT03116126
Sponsor: Imperial College London
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-01-04
Primary completion: 2024-08-05
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.